Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI113428

Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance.

J J Shelmet, G A Reichard, C L Skutches, R D Hoeldtke, O E Owen, and G Boden

Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Find articles by Shelmet, J. in: PubMed | Google Scholar

Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Find articles by Reichard, G. in: PubMed | Google Scholar

Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Find articles by Skutches, C. in: PubMed | Google Scholar

Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Find articles by Hoeldtke, R. in: PubMed | Google Scholar

Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Find articles by Owen, O. in: PubMed | Google Scholar

Department of Medicine, Temple University Hospital, Philadelphia, Pennsylvania 19140.

Find articles by Boden, G. in: PubMed | Google Scholar

Published April 1, 1988 - More info

Published in Volume 81, Issue 4 on April 1, 1988
J Clin Invest. 1988;81(4):1137–1145. https://doi.org/10.1172/JCI113428.
© 1988 The American Society for Clinical Investigation
Published April 1, 1988 - Version history
View PDF
Abstract

To study the mechanism of the diabetogenic action of ethanol, ethanol (0.75 g/kg over 30 min) and then glucose (0.5 g/kg over 5 min) were infused intravenously into six normal males. During the 4-h study, 21.8 +/- 2.1 g of ethanol was metabolized and oxidized to CO2 and H2O. Ethanol decreased total body fat oxidation by 79% and protein oxidation by 39%, and almost completely abolished the 249% rise in carbohydrate (CHO) oxidation seen in controls after glucose infusion. Ethanol decreased the basal rate of glucose appearance (GRa) by 30% and the basal rate of glucose disappearance (GRd) by 38%, potentiated glucose-stimulated insulin release by 54%, and had no effect on glucose tolerance. In hyperinsulinemic-euglycemic clamp studies, ethanol caused a 36% decrease in glucose disposal. We conclude that ethanol was a preferred fuel preventing fat, and to lesser degrees, CHO and protein, from being oxidized. It also caused acute insulin resistance which was compensated for by hypersecretion of insulin.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 1137
page 1137
icon of scanned page 1138
page 1138
icon of scanned page 1139
page 1139
icon of scanned page 1140
page 1140
icon of scanned page 1141
page 1141
icon of scanned page 1142
page 1142
icon of scanned page 1143
page 1143
icon of scanned page 1144
page 1144
icon of scanned page 1145
page 1145
Version history
  • Version 1 (April 1, 1988): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts